JP2014503599A5 - - Google Patents

Download PDF

Info

Publication number
JP2014503599A5
JP2014503599A5 JP2013551904A JP2013551904A JP2014503599A5 JP 2014503599 A5 JP2014503599 A5 JP 2014503599A5 JP 2013551904 A JP2013551904 A JP 2013551904A JP 2013551904 A JP2013551904 A JP 2013551904A JP 2014503599 A5 JP2014503599 A5 JP 2014503599A5
Authority
JP
Japan
Prior art keywords
octane
azabicyclo
oxo
pyridinecarboxamide
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013551904A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014503599A (ja
JP5921576B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2012/000648 external-priority patent/WO2012102580A1/en
Publication of JP2014503599A publication Critical patent/JP2014503599A/ja
Publication of JP2014503599A5 publication Critical patent/JP2014503599A5/ja
Application granted granted Critical
Publication of JP5921576B2 publication Critical patent/JP5921576B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013551904A 2011-01-28 2012-01-30 ピリドン誘導体を含む医薬組成物 Expired - Fee Related JP5921576B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2011-0008960 2011-01-28
KR20110008960 2011-01-28
PCT/KR2012/000648 WO2012102580A1 (en) 2011-01-28 2012-01-30 Pharmaceutical composition comprising pyridone derivatives

Publications (3)

Publication Number Publication Date
JP2014503599A JP2014503599A (ja) 2014-02-13
JP2014503599A5 true JP2014503599A5 (https=) 2014-12-25
JP5921576B2 JP5921576B2 (ja) 2016-05-24

Family

ID=46581019

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013551904A Expired - Fee Related JP5921576B2 (ja) 2011-01-28 2012-01-30 ピリドン誘導体を含む医薬組成物

Country Status (8)

Country Link
US (1) US8716309B2 (https=)
EP (1) EP2668186B1 (https=)
JP (1) JP5921576B2 (https=)
KR (1) KR101925971B1 (https=)
CN (1) CN103328477B (https=)
CA (1) CA2824467C (https=)
ES (1) ES2634204T3 (https=)
WO (1) WO2012102580A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101928505B1 (ko) 2011-01-28 2018-12-12 에스케이바이오팜 주식회사 피리돈 유도체 및 이를 포함하는 약학적 조성물
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
MX382781B (es) 2014-04-02 2025-03-13 Intermune Inc Piridinonas anti-fibroticas.
EP3259262A4 (en) * 2015-02-17 2018-08-01 Mapi Pharma Limited Process and intermediates for the preparation of perampanel
AR107928A1 (es) 2016-03-22 2018-06-28 Merck Sharp & Dohme Moduladores alostéricos de receptores de acetilcolina nicotínicos
WO2019028062A1 (en) * 2017-07-31 2019-02-07 Washington University PIRFENIDONE DERIVATIVES FOR MODULATION OF B-LYMPHOCYTE ACTIVITY AND PROTECTION OF ORGANS
RS66290B1 (sr) 2018-05-01 2025-01-31 Merck Sharp & Dohme Llc Spiropiperidin alosterični modulatori nikotinskih acetiholinskih receptora
CN109293507B (zh) * 2018-10-12 2020-12-18 河北科技大学 4-甲氧基甲烯基-2-烯戊二酸二甲酯的合成方法及其应用
EP4054569A4 (en) 2019-11-05 2023-10-25 Merck Sharp & Dohme LLC ALLOSTERIC SPIROPIPERIDINE MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404138A (en) * 1982-06-22 1983-09-13 Warner-Lambert Company 3-[2-(Azabicyclo) ethyl]-1,2,3,4-tetrahydro-5H-[1]benzopyrano[3,4-c]pyridin-5-ones
TR200102162T2 (tr) * 1999-01-29 2001-12-21 Abbott Laboratories Nikotinik asetilkolin reseptör ligandları olarak diazabisiklik türevler.
SE0000540D0 (sv) * 2000-02-18 2000-02-18 Astrazeneca Ab New compounds
US6569865B2 (en) * 2001-06-01 2003-05-27 Astrazeneca Ab Spiro 1-azabicyclo[2.2.2]octane-3,2′(3′h)-furo[2,3-b]pyridine
AU2002339810A1 (en) * 2001-10-16 2003-04-28 Astrazeneca Ab Azabicyclic compounds for the treatment of fibromyalgia syndrome
FR2834511B1 (fr) * 2002-01-07 2004-02-13 Sanofi Synthelabo Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique
EP2344636B1 (en) * 2008-10-09 2017-12-06 Howard Hughes Medical Institute Novel chimeric ligand-gated ion channels and methods of use thereof
US20110262407A1 (en) * 2008-11-11 2011-10-27 Targacept, Inc. Treatment with alpha7 selective ligands
KR101928505B1 (ko) * 2011-01-28 2018-12-12 에스케이바이오팜 주식회사 피리돈 유도체 및 이를 포함하는 약학적 조성물

Similar Documents

Publication Publication Date Title
JP2014503599A5 (https=)
JP2008516986A5 (https=)
PH12019501707A1 (en) N-[4-fluoro-5-[[(2s,4s)-2-methyl-4-[(5-methyl-1,2,4-oxadiazol-3-yl)methoxy]-1-piperidyl]methyl]thiazol-2-yl]acetamide as oga inhibitor
JP2011503103A5 (https=)
RU2009133794A (ru) Гербициды на основе замещенного n-оксида пиридина
JP2009542721A5 (https=)
JP2020502092A5 (https=)
PE20090435A1 (es) Inhibidores de tetrahidropiranocromeno de gamma secretasa
JP2019505541A5 (https=)
DK1826197T3 (da) Aminocarboxylsyrederivater og medicinsk anvendelse deraf
JP2006502119A5 (https=)
JP2014526549A5 (https=)
BRPI0518360A2 (pt) composto e sais farmaceuticamente aceitÁveis do mesmo, composiÇço farmacÊutica, uso de um composto, e, processo para preparar um composto ou um sal farmaceuticamente aceitÁvel do mesmo
JP2010138190A5 (https=)
BG108650A (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
JP2017214387A5 (https=)
RU2018103198A (ru) Новые соединения циклического n-карбоксамида, применяемые в качестве гербицидов
WO2002085901A8 (en) Substituted azabicyclic moieties for the treatment of disease (nicotinic acethylcholine receptor agonists)
RU2011105151A (ru) Азольные соединения
JP2005506308A5 (https=)
WO2003070731A3 (en) Azabicyclic compounds for the treatment of disease
JP2017502063A5 (https=)
NO20075022L (no) (7-(2-(4-(3-trifluormetylfenyl)-1,2,3,6-tetrahydropyrid-1-yl)etyl) isokinolinbesylatsalt, fremstilling og terapeutiske anvendelser derav
JP2012518634A5 (https=)
PE20201151A1 (es) Moduladores alostericos positivos del receptor de dopamina d1